// App-Quantinova.ai

2302 : Tissue Factor Pathway Inhibitor Modulates Fibrin Deposition In The Brain In a Manner That Is Independent Of Thrombomodulin and Activated Protein C

Researchers

Presenter

  • Susan A. Maroney

Principal Investigators

  • Paul E. R. Ellery

  • Nicholas d Martinez

  • Mark Zogg

  • Gary E. Gilbert

  • Hartmut Weiler

  • Alan E. Mast

Medical Centers

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Research and Medicine, VA Boston Healthcare System and Harvard Medical School, West Roxbury, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Vasodilation dysfunction

  • Venous thrombosis

  • Dementia

  • Stroke

Biomarkers

  • Nucleoside diphosphate kinase A

  • Cluster of Differentiation 31

  • Coagulation Factor III, Tissue Factor

  • Sperm Acrosome Associated 9

  • Tissue factor pathway inhibitor

Drug/Treatment

  • Phosphatidylserine

  • Thrombomodulin alfa

  • Protein C

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim